The transcription factor Foxp1 plays a regulatory role in the HIF-1α-HK2 pathway, which can improve the high glycolysis of tumor ECs and limit tumor angiogenesis, thereby effectively slowing down tumor growth [63]. Here, HK2 is linked to neoplasm.